Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer aims for No. 1 in Japanese generics
Fierce Pharma
Monday, February 1, 2010 - 11:26am
tags:
Pfizer, generics, Japan, Teva Pharmaceuticals
InterMune gets March FDA review for lung drug
Yahoo/AP
Monday, February 1, 2010 - 11:14am
tags:
FDA, InterMune, pirfenidone
[video] Trading Smallcap Biotech
TheStreet.com
Monday, February 1, 2010 - 11:08am
tags:
Savient, Medivation, Prolor, Synta, Chelsea Therapeutics, Halozyme, NeurogesX
Will Ironwood's $267M IPO gamble pay off?
Fierce Biotech
Monday, February 1, 2010 - 10:34am
tags:
Ironwood, IPOs
Cell Therapeutics' Upcoming FDA Worries
TheStreet.com
Monday, February 1, 2010 - 10:23am
tags:
FDA, Cell Therapeutics, EXTEND, pixantrone
Bargains to be found in health-care stocks
Yahoo/Fortune
Monday, February 1, 2010 - 10:22am
tags:
Amgen, Genzyme, Gilead Sciences
Geron Explores New Application for Hampered Alzheimer's Drug
Seeking Alpha
Monday, February 1, 2010 - 10:16am
tags:
Alzheimer's disease, Geron
Biotech Events to Watch in 2010: FDA Approvals, Expected Deals and Surprises!
BNET Pharma
Monday, February 1, 2010 - 10:11am
tags:
biotech, FDA, Cadence Pharmaceuticals, Acetavance, Gilead Sciences, Cayston, velaglucerase, Shire, Exenatide LAR, Amylin, Cephalon, NUVIGIL, Cell Therapeutics, pixantrone, Dendreon, Provenge
Judge refuses to dismiss Fosamax case, sets trial
Reuters
Monday, February 1, 2010 - 10:09am
tags:
osteoporosis, Fosamax, trials, Merck
Five Drugs To Watch (Assuming FDA Approval)
Pharmalot
Monday, February 1, 2010 - 10:07am
tags:
FDA, Dendreon, Provenge, Victoza, Novo Nordisk, Qnexa, Vivus, Prolia, Amgen, Bayer, JNJ, Xarelto
Drug stocks gain; Warner Chilcott slides
Marketwatch
Monday, February 1, 2010 - 10:06am
tags:
Warner Chilcott, drug stocks
Cephalon acquires Swiss drugmaker Mepha AG
Yahoo/AP
Monday, February 1, 2010 - 10:05am
tags:
Mepha, M&A, Cephalon
Daiichi Sankyo Seeks to Sell Long-Acting Flu Drug
Bloomberg
Monday, February 1, 2010 - 9:57am
tags:
Daiichi Sankyo, Japan, Flu, antivirals, Laninamivir
Venture Financing Comes Through for Biotech
Seeking Alpha
Monday, February 1, 2010 - 9:55am
tags:
biotech, venture capital, Eli Lilly, AstraZeneca, BG Medicine
Boston Sci to pay J&J $1.7 bln in patent dispute
Marketwatch
Monday, February 1, 2010 - 9:54am
tags:
settlements, Boston Scientific, JNJ, stents
Novartis Makes Notable CEO Pick
Seeking Alpha
Monday, February 1, 2010 - 9:44am
tags:
Novartis, Pharma CEOs, Joe Jimenez
GSK to announce more than 3,000 job cuts
FT.com
Monday, February 1, 2010 - 9:43am
tags:
GSK, layoffs
Betting on the aging of America
Investment News
Sunday, January 31, 2010 - 11:37am
tags:
investors
CellProthera achieves a revolutionary breakthrough in the treatment of myocardial infarction with the support of the Alsace Region and the Alsace BioValley biocluster
Pipeline Review
Sunday, January 31, 2010 - 11:26am
tags:
CellProthera, biotech, myocardial infarction
Despite M&A slowdown, pharmaceutical deals remained plentiful in 2009
Crain's Chicago Business
Sunday, January 31, 2010 - 11:24am
tags:
M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.